Research Topics
| Robert D BakerSummaryAffiliation: State University of New York at Buffalo Country: USA Publications
| Collaborators
|
Detail Information
Publications
Infantile gastroesophageal reflux in a hospital settingSusan S Baker
Department of Pediatrics University at Buffalo, Women and Children s Hospital, 219 Bryant Street, Buffalo, NY 14222, USA
BMC Pediatr 8:11. 2008..The aim of this study is to describe the demographics of children with gastroesophageal reflux discharged from the hospital during the first two years of life...
Infant formula safetyRobert D Baker
Digestive Disease and Nutrition Center, Children's Hospital of Buffalo, Buffalo, NY 14222, USA
Pediatrics 110:833-5. 2002
Human milk substitutes. An American perspectiveR Baker
Digestive Disease and Nutrition Center, Children s Hospital of Buffalo, Buffalo, NY 14222, USA
Minerva Pediatr 55:195-207. 2003..Formulas will continue to be used and will continue to be needed. Improving and assuring the adequacy and safety of infant formulas is an increasingly difficult challenge...
Response to pegylated interferon alpha-2b and ribavirin in children with chronic hepatitis CRobert D Baker
Women and Children s Hospital of Buffalo, University at Buffalo, School of Medicine and Biomedical Sciences, State University of New York, Buffalo, NY 14222, USA
J Clin Gastroenterol 41:111-4. 2007..The purpose of this communication is to report our observations on the treatment of a diverse group of adolescent patients who were chronically infected with hepatitis C and received pegylated interferon and ribavirin...
Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitisWael N Sayej
Digestive Diseases and Nutrition Center, Women and Children s Hospital of Buffalo, University at Buffalo, NY 14222, USA
J Pediatr Gastroenterol Nutr 49:393-9. 2009..We hypothesize that the treatment with a high-dose proton pump inhibitor (HDPPI) helps differentiate EE from noneosinophilic esophagitis (NEE)...
Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASHLixin Zhu
Digestive Diseases and Nutrition Center, Department of Pediatrics, State University of New York at Buffalo, Buffalo, NY 14214, USA
Hepatology 57:601-9. 2013..We postulate that the distinct composition of the gut microbiome among NASH, obese, and healthy controls could offer a target for intervention or a marker for disease...
Effect of dietary advanced glycation end products on mouse liverRaza Patel
Department of Pediatrics, Digestive Diseases and Nutrition Center, State University of New York, Women and Children s Hospital of Buffalo, Buffalo, New York, United States of America
PLoS ONE 7:e35143. 2012..Previous studies suggest that dietary advanced glycation end products (AGEs) can cause oxidative stress in liver. We aim to study the effects of dietary AGEs on liver health and their possible role in the pathogenesis of NASH...
Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosisDrucy Borowitz
Department of Pediatrics, Women and Children s Hospital of Buffalo, State University of New York at Buffalo, 219 Bryant Street, Buffalo, NY 14222, USA
J Pediatr 145:322-6. 2004..To test the hypothesis that some patients with cystic fibrosis (CF) are misclassified as pancreatic insufficient, using fecal elastase-1 (FE-1) to define pancreatic status...
Pancreatic exocrine function in patients with cystic fibrosisSusan S Baker
Digestive Diseases and Nutrition Center, Women and Children s Hospital, 219 Bryant Street, Buffalo, NY 14222, USA
Curr Gastroenterol Rep 7:227-33. 2005..Growth, number of stools, frequency of abdominal pain, and flatulence cannot be used to adjust enzyme doses...
Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosisLixin Zhu
Department of Pediatrics, Digestive Diseases and Nutrition Center, The State University of New York, Buffalo, NY 14214, USA
Metabolism 60:1001-11. 2011..Our study promises a simple method for the determination of why hepatic steatosis occurs in individual patients. This method may allow specific targeting of therapeutic treatments in individual patients...
Varicella immunity in inflammatory bowel diseaseFaazia Ansari
Digestive Diseases and Nutrition Center, Department of Pediatrics, University at Buffalo, Buffalo, NY 14222, USA
J Pediatr Gastroenterol Nutr 53:386-8. 2011..Our objective was to show that at least 90% of patients newly diagnosed as having IBD had antibodies against varicella zoster and were protected by vaccination or natural disease...
Increasing incidence of community-associated atypical Clostridium difficile disease in childrenSusan S Baker
University at Buffalo, The State University of New York, School of Medicine and Biomedical Sciences, and Women and Children s Hospital of Buffalo, Buffalo, NY, USA
Clin Pediatr (Phila) 49:644-7. 2010..Each child responded to treatment with metronidazole with resolution of their symptoms. These data suggest that community-associated C difficile is increasing and may produce atypical disease and lead to misdiagnosis...
Vitamin and mineral status in patients with inflammatory bowel diseaseRazan H Alkhouri
Digestive Disease and Nutrition Center, SUNY at Buffalo, Buffalo, NY, USA
J Pediatr Gastroenterol Nutr 56:89-92. 2013..The aim of the study is to investigate the prevalence of vitamin and zinc deficiencies in patients with newly diagnosed IBD compared with a control group...
Childhood esophagitis: then and nowJoyce J Lee
Women and Children s Hospital of Buffalo, Buffalo, NY, USA
J Pediatr Gastroenterol Nutr 48:37-40. 2009..In children, the intraepithelial eosinophil is considered the hallmark of esophageal inflammation. This study compares the prevalence of intraepithelial eosinophils in esophageal biopsies obtained from 1980-1988 and 2001-2002...
Consensus report on nutrition for pediatric patients with cystic fibrosisDrucy Borowitz
Digestive Disease and Nutrition Center, Children's Hospital of Buffalo, 219 Bryant Street, Buffalo, NY 14222, USA
J Pediatr Gastroenterol Nutr 35:246-59. 2002
Pancreatic enzyme therapy and clinical outcomes in patients with cystic fibrosisSusan S Baker
Department of Pediatrics, Women and Children's Hospital of Buffalo, State University of New York at Buffalo, USA
J Pediatr 146:189-93. 2005..CONCLUSION: PET dose is not correlated with growth or gastrointestinal symptoms. More sensitive outcome measures of the effectiveness of PET in patients with CF are needed to guide treatment of PI...
Gastrointestinal outcomes and confounders in cystic fibrosisDrucy Borowitz
J Pediatr Gastroenterol Nutr 41:273-85. 2005
Use of soy protein-based formulas in infant feedingJatinder Bhatia
Pediatrics 121:1062-8. 2008..This report reviews the limited indications and contraindications of soy formulas. It will also review the potential harmful effects of soy protein-based formulas and the phytoestrogens contained in these formulas...
Liver biopsy results in patients with sickle cell disease on chronic transfusions: poor correlation with ferritin levelsLina B Karam
Department of Pediatric Gastroenterology, University of Michigan Medical Center, Ann Arbor, Michigan, USA
Pediatr Blood Cancer 50:62-5. 2008..The aim of this study was to determine whether serum ferritin levels correlated with liver iron content in sickle cell patients on chronic transfusion...
